Product Name | MF | CAS | Details |
---|
2-Buten-1-one, 1-(5-bromo-4-methyl-2-thienyl)-4,4,4-trifluoro-3-(3,4,5-trichlorophenyl)- | C15H7BrCl3F3OS | 1613733-72-4 | Details |
1H-Indole-2-carboxylic acid, 7-fluoro-2,3-dihydro-, methyl ester | C10H10FNO2 | 1779447-21-0 | Details |
tetrahydroharmine | C13H16N2O | 17019-01-1 | Details |
2,2,2-trifluoro-1-(3,4,5-trichlorophenyl)ethanone | C8H2Cl3F3O | 158401-00-4 | Details |
synthesis-24 | C5H2ClF3N2 | 1514-96-1 | Details |
Medetomidine Impurity | C20H22N2O | 1587636-55-2 | Details |
2,5-Piperazinedione, 3-(1H-indol-3-ylmethyl)-1-methyl-, (3R)- | C14H15N3O2 | 1422164-53-1 | Details |
synthesis-1 | C6H6ClNO | 17609-80-2 | Details |
Avibactam INT 1 | C17H24N2O7 | 1416134-48-9 | Details |
1-N-Boc-3-hydroxyazetidine | C8H15NO3 | 141699-55-0 | Details |
Ropivacaine impurity | C12H14N2O3 | 1786560-34-6 | Details |
Fenofibric acid-002 | C16H15ClO2 | 154356-97-5 | Details |
mexidol-002 | C8H11NO | 1777826-23-9 | Details |
mildronate-010 | C6H14N2O2 | 153050-92-1 | Details |
2H-Thieno[3,2-e]-1,2-thiazin-4-ol, 6-chloro-3,4-dihydro-, 1,1-dioxide, (4R)- | C6H6ClNO3S2 | 1413393-01-7 | Details |
Articaine-017 | C14H23ClN2O3S | 161449-05-4 | Details |
1398610-09-7 | C20H14Cl2F4N2O2.C7H8O3S | 1398610-09-7 | Details |
CCMO-36 | C12H15ClO | 17380-83-5 | Details |
Benzenemethanol, 4-methoxy-, 4-methylbenzenesulfonate | C15H16O4S | 14670-03-2 | Details |
Brinzolamide impurity | C6H7BrClNO3S2 | 174139-67-4 | Details |
2-METHOXY-5-TRIFLUOROMETHYLPHENYL ISOCYANATE | C9H6F3NO2 | 16588-75-3 | Details |
Isoxazole, 3-(5-bromo-4-methyl-2-thienyl)-4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)- | C15H8BrCl3F3NOS | 1613733-73-5 | Details |
Benzamide, 2-bromo-6-fluoro-N-methyl- | C8H7BrFNO | 1436306-43-2 | Details |
CeftarolineFosamil-009-Br | C9H9BrN2S2 | 1427207-49-5 | Details |
Articaine-012 | C10H13NO3S | 1779088-71-9 | Details |
Spiro[azetidine-3,1'(3'H)-isobenzofuran]-1-carboxylic acid, 5'-[3-(3,5-dichloro-4-fluorophenyl)-4,4,4-trifluoro-1-oxo-2-buten-1-yl]-, 1,1-dimethylethyl ester | C25H21Cl2F4NO4 | 1398610-04-2 | Details |
TPST-1120 | 1454928-51-8 | Details |
Spiro[azetidine-3,1'(3'H)-isobenzofuran]-1-carboxylic acid, 5'-acetyl-, 1,1-diMethylethyl ester | C17H21NO4 | 1398609-81-8 | Details |
Brinzolamide impurity | C10H14N2O5S3 | 171273-35-1 | Details |
1383608-60-3 | 1383608-60-3 | Details |
3,3,5-trimethylcyclohexyl 2-oxo-2-phenylacetate | C17H22O3 | 16623-22-6 | Details |
synthesis-18 | C7H13NO2 | 138421-23-5 | Details |
Spiro[azetidine-3,1'(3'H)-isobenzofuran], 5'-[(5R)-5-(3,5-dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]- | C20H14Cl2F4N2O2 | 1398610-08-6 | Details |
S-217622 | C9H9ClN2O3 | 13852-52-3 | Details |
Benzamide, 4-[3-(3,5-dichlorophenyl)-4,4,4-trifluoro-1-oxo-2-buten-1-yl]-2-methyl-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]- | C22H16Cl2F6N2O3 | 1422465-94-8 | Details |
brinzolamide | C12H21N3O5S3 | 154127-19-2 | Details |
2-Furancarboxylicacid,tetrahydro-,1-methylethylester,(R)-(9CI) | C8H14O3 | 178461-68-2 | Details |
OLANEXIDINE | C17H27Cl2N5 | 146510-36-3 | Details |
3,4-Dihydro-2-(3-methoxypropyl)-4-oxo-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide | C10H14N2O6S3 | 154127-41-0 | Details |
1-(3-Methoxyphenyl)piperazine hydrochloride | C11H17ClN2O | 16015-70-6 | Details |
Olanexidine Impurity | 147028-65-7 | Details |
Ropivacaine-iPr | C17H26N2O | 175888-75-2 | Details |
synthesis-23 | C2H7NO3S | 162894-76-0 | Details |
Ropivacaine impurity | C12H14N2O3 | 1786841-18-6 | Details |
CINACALCET-001-R | C11H11BF4N4O | 1630761-22-6 | Details |
TPST-1120 | C35H39N5O3S | 1454925-59-7 | Details |
2H-Thieno[3,2-e]-1,2-thiazin-4-ol, 6-chloro-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)- | C10H14ClNO4S2 | 1413393-04-0 | Details |
2-Propanol, 1-[[2-(2-methoxyphenoxy)ethyl]methylamino]-3-[(9-methyl-9H-carbazol-4-yl)oxy]- | C26H30N2O4 | 1479052-24-8 | Details |
TPST-1120 | C10H13BrN2O | 1454928-45-0 | Details |
Spiro[azetidine-3,1'(3'H)-isobenzofuran], 5'-[(5S)-5-(3,5-dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-, 4-methylbenzenesulfonate (1:1) | C27H22Cl2F4N2O5S | 1398610-11-1 | Details |
1,1-Dimethylethyl 5′-[(2E)-3-(3,5-dichloro-4-fluorophenyl)-4,4,4-trifluoro-1-oxo-2-buten-1-yl]spiro[azetidine-3,1′(3′H)-isobenzofuran]-1-carboxylate | C25H21Cl2F4NO4 | 1398610-14-4 | Details |
N-(2,4-dimethylphenyl)piperidine-2-carboxamide | C14H20N2O | 1583238-33-8 | Details |
Ropivacaine impurity | C13H16N2O3 | 1543937-58-1 | Details |
Palbociclib-029 | C9H12N4O2 | 1566082-34-5 | Details |
Remdesivir-003-R | C9H19NO2 | 1689993-65-4 | Details |
1,3-Benzodioxole-5-carboxylic acid, 4-bromo-7-(phenylmethoxy)-, methyl ester | C16H13BrO5 | 142531-44-0 | Details |
Ethanone, 1-(3-bromo-5-chlorophenyl)-2,2,2-trifluoro- | C8H3BrClF3O | 1655515-91-5 | Details |
TPST-1120 | C30H42BN3O3 | 1454928-56-3 | Details |
CeftarolineFosamil-009 | C9H9N2S2+ | 1427207-52-0 | Details |
TPST-1120 | C29H35N5O | 1454925-54-2 | Details |
synthesis-24 | C3H3FN2 | 14521-81-4 | Details |
Acetic acid, 2-(3-chloro-5-cyanophenoxy)-, ethyl ester | C11H10ClNO3 | 1613307-27-9 | Details |
Naltrexone Ethylene Ketal | C22H27NO5 | 16676-32-7 | Details |
1(3H)-Isobenzofuranone, 3-(1-hydroxybutyl)- | C12H14O3 | 168288-19-5 | Details |
TPST-1120 | C13H16BrN3O | 1454928-46-1 | Details |
methyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C33H38N6O6 | 1408238-39-0 | Details |
3-(2-FLUORO-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER | C11H11FO3 | 1479-24-9 | Details |
Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]- | C15H15ClO2 | 1408077-50-8 | Details |
Clevidipine Impurity 17 | C10H8Cl2O | 1685245-63-9 | Details |
4-(3-NITRO-PYRIDIN-2-YL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER | C14H20N4O4 | 153473-24-6 | Details |
1-ACETYL-2-METHYLBENZIMIDAZOLE | C10H10N2O | 14678-81-0 | Details |
S-217622 | C9H9ClN2O3 | 13852-50-1 | Details |
β-Alanine, N-(2-bromo-6-fluorophenyl)-, methyl ester | C10H11BrFNO2 | 1697691-31-8 | Details |
2-Propenamide, N-(2-bromo-6-fluorophenyl)- | C9H7BrFNO | 1695869-28-3 | Details |
1H-Pyrrole-2-carbonitrile,1-amino-(9CI) | C5H5N3 | 159326-66-6 | Details |
Ethyl 3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylate | C8H10F2N2O2 | 141573-95-7 | Details |
BrinzolaMide iMpurity | C10H16N2O6S3 | 165117-54-4 | Details |
PSQ-IM-B | C17H17N5O2 | 1430561-06-0 | Details |
4-Bromo-n-methoxy-n,3-dimethylbenzamide | C10H12BrNO2 | 170230-01-0 | Details |
Oclacitinib maleate | C19H27N5O6S | 1640292-55-2 | Details |
(4-(hydroxyimino)methyl)-2-methylbenzoic acid | C9H9NO3 | 1437051-93-8 | Details |
1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea | C19H23FN2O2 | 1388858-78-3 | Details |
Methisosildenafil impure | C25H36N6O4S | 1425504-78-4 | Details |
XGZZHZMWIXFATA-VQNNHZPYSA-N | C28H32N2O5 | 163712-68-3 | Details |
Ropivacaine impurity | C13H16N2O3 | 1786518-57-7 | Details |
2-BUTYNE-1,4-DIOL DIACETATE | C8H10O4 | 1573-17-7 | Details |
Cromoglicic acid | C23H16O11 | 16110-51-3 | Details |
miramistin | C26H47ClN2O | 15809-19-5 | Details |
CeftarolineFosamil-009-Cl | C9H9ClN2S2 | 1427207-56-4 | Details |
Spiro[azetidine-3,1'(3'H)-isobenzofuran], 5'-[(5S)-5-(3,5-dichloro-4-fluorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]- | C20H14Cl2F4N2O2 | 1398610-10-0 | Details |
Sevelamer hydrochloride | C6H13Cl2NO | 152751-57-0 | Details |
Spiro[azetidine-3,1'(3'H)-isobenzofuran]-1-carboxylic acid, 5'-[(2Z)-3-(3,5-dichloro-4-fluorophenyl)-4,4,4-trifluoro-1-oxo-2-buten-1-yl]-, 1,1-dimethylethyl ester | C25H21Cl2F4NO4 | 1398609-82-9 | Details |
TPST-1120 | C13H18BrN3O2 | 1454928-85-8 | Details |
1-(3-Methoxyphenyl)piperazine | C11H16N2O | 16015-71-7 | Details |
synthesis-19 | C8H4ClF3N2 | 157764-10-8 | Details |
tert-butyl 5'-bromo-3'H-spiro[azetidine-3,1'-[2]benzofuran]-1-carboxylate | C15H18BrNO3 | 1398609-80-7 | Details |
2-(DIMETHYLAMINO)ETHYL-p-AMINOBENZOATE HYDROCHLORIDE | C11H16ClN2O2- | 17599-02-9 | Details |
3,4-Dibromo-5-methyl-benzoic acid | C8H6Br2O2 | 1564638-18-1 | Details |
methyl 7-(benzyloxy)benzo[d][1,3]dioxole-5-carboxylate | C16H14O5 | 142531-43-9 | Details |
(S)-methyl 2-amino-3-((S)-2-oxopyrrolidin-3-yl)propanoate hydrochloride | C8H15ClN2O3 | 1429218-41-6 | Details |
Product Total: Product Page: | ||||
67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 |